Global /South Korea /Healthcare /Drug Manufacturers - General /072020

Choong Ang Vaccine Laboratory Co., Ltd.

072020

• KRX: 072020 • Delayed

10,140KRW 2.7%

6.72 USD

As of 18 June 2026, Choong Ang Vaccine Laboratory Co., Ltd. has a market cap of $63.54M USD, ranking #28863 globally and #1566 in South Korea. It ranks #2623 in the Healthcare sector, and #929 in the Drug Manufacturers - General industry.

Global Rank

28863

Country Rank

1566

Sector Rank

2623

Industry Rank

929

Key Stats

Market Cap

$63.54MUSD

95.91B KRW

Revenue (TTM)

$25.96MUSD

39.19B KRW

EBITDA (TTM)

$6.63MUSD

10.01B KRW

Net Income (TTM)

$2.42MUSD

3.65B KRW

EBITDA Margin

26%

Profit Margin

9.3%

PE Ratio

27.0

PS Ratio

2.4

PB Ratio

1.0

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

In-Joong Yoon open_in_new

Employees

167

Founded

1968

Website

cavac.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.7%	1.4%	8.1%	3.4%	2.5%	0.7%	1.1%	-5.1%	-45%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	072020 (주)중앙백신연구소 ISIN: KR7072020001 Shares Out.: Shares Outstanding: 9.157M¹ Shares Float: 5.498M² TV: TradingView: KRX: 072020 SA: Stock Analysis: KRX: 072020 YF: Yahoo Finance: 072020.KS GF: Google Finance: KRX: 072020 BA: Barron's: 072020 MS: Morningstar: XKRX: 072020	10,140 KRW	TV: TradingView: KRX: 072020 SA: Stock Analysis: KRX: 072020 YF: Yahoo Finance: 072020.KS GF: Google Finance: KRX: 072020 BA: Barron's: 072020 MS: Morningstar: XKRX: 072020

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Choong Ang Vaccine Laboratory Co., Ltd.

Choong Ang Vaccine Laboratory Co., Ltd. engages in the research, development, manufacturing, and sale of animal vaccines in South Korea, Asia, Africa, and the United States. It offers swine, poultry, cattle, canine, feline, wild boar, and raccoon vaccines under the SuiShot, PoulShot, BoviShot, CaniShot, and FeliShot brands. The company was founded in 1968 and is headquartered in Daejeon, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.22B 13.91T KRW 14K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.83B 10.3T KRW 11K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.28B 7.97T KRW 8K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$5.0B 7.55T KRW 8K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.58B 6.92T KRW 7K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.48B 6.76T KRW 7K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 1M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 861K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 567K%	97.4	United States
Roche Holding AG SIX: RO	$323.08B 256.25B CHF 508K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.5B 215.59B GBP 455K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$275.99B 218.9B CHF 434K%	20.5	Switzerland

chevron_leftBack